Rodolfo Chicas-Sett

418 total citations
29 papers, 299 citations indexed

About

Rodolfo Chicas-Sett is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Rodolfo Chicas-Sett has authored 29 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Radiation. Recurrent topics in Rodolfo Chicas-Sett's work include Cancer Immunotherapy and Biomarkers (9 papers), Advanced Radiotherapy Techniques (7 papers) and Gastrointestinal motility and disorders (6 papers). Rodolfo Chicas-Sett is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Advanced Radiotherapy Techniques (7 papers) and Gastrointestinal motility and disorders (6 papers). Rodolfo Chicas-Sett collaborates with scholars based in Spain and Sweden. Rodolfo Chicas-Sett's co-authors include Delvys Rodríguez‐Abreu, Pedro C. Lara, M. Lloret, Jesús Blanco, Felipe Couñago, Isabel Barragán, Samuel Hernández, S. Roldán, José Pérez‐Calatayud and M. Murcia and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Rodolfo Chicas-Sett

27 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodolfo Chicas-Sett Spain 8 175 144 57 43 37 29 299
Mark A. Ziegler United States 6 181 1.0× 89 0.6× 21 0.4× 69 1.6× 38 1.0× 8 254
Gregory Vlacich United States 10 89 0.5× 152 1.1× 24 0.4× 133 3.1× 52 1.4× 23 324
Felix Ho United States 8 198 1.1× 81 0.6× 38 0.7× 121 2.8× 9 0.2× 16 298
Zeming Mo China 7 164 0.9× 113 0.8× 67 1.2× 85 2.0× 32 0.9× 11 369
Eren Celik Germany 11 128 0.7× 112 0.8× 32 0.6× 52 1.2× 36 1.0× 25 270
D. Spielsinger United States 5 268 1.5× 125 0.9× 96 1.7× 76 1.8× 17 0.5× 11 352
Kilian Salerno May United States 7 136 0.8× 88 0.6× 12 0.2× 50 1.2× 10 0.3× 12 233
Manabu Arai Japan 11 190 1.1× 41 0.3× 45 0.8× 125 2.9× 20 0.5× 14 358
Fernando M. Gómez Spain 10 89 0.5× 158 1.1× 31 0.5× 57 1.3× 16 0.4× 24 307

Countries citing papers authored by Rodolfo Chicas-Sett

Since Specialization
Citations

This map shows the geographic impact of Rodolfo Chicas-Sett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodolfo Chicas-Sett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodolfo Chicas-Sett more than expected).

Fields of papers citing papers by Rodolfo Chicas-Sett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodolfo Chicas-Sett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodolfo Chicas-Sett. The network helps show where Rodolfo Chicas-Sett may publish in the future.

Co-authorship network of co-authors of Rodolfo Chicas-Sett

This figure shows the co-authorship network connecting the top 25 collaborators of Rodolfo Chicas-Sett. A scholar is included among the top collaborators of Rodolfo Chicas-Sett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodolfo Chicas-Sett. Rodolfo Chicas-Sett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Oliver, Javier, Elísabeth Pérez-Ruiz, José Carlos Benítez, et al.. (2024). Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer. International Journal of Molecular Sciences. 25(8). 4533–4533. 5 indexed citations
4.
Oliver, Javier, Arthur Eumann Mesas, Antonio Rueda‐Domínguez, et al.. (2023). Dynamic Exosome Analysis to Predict Response to the Combination of SABR and Immunotherapy in Oligoprogressive Disease. International Journal of Radiation Oncology*Biology*Physics. 117(2). e274–e275. 1 indexed citations
5.
Chicas-Sett, Rodolfo, et al.. (2023). Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer. Frontiers in Oncology. 12. 1092875–1092875. 6 indexed citations
6.
Chicas-Sett, Rodolfo, Delvys Rodríguez‐Abreu, Samuel Hernández, et al.. (2022). Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study. International Journal of Radiation Oncology*Biology*Physics. 114(4). 655–665. 32 indexed citations
7.
Conde-Moreno, Antonio J., Aranzazu González del Alba, Fernando López‐Campos, et al.. (2022). Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer. Clinical & Translational Oncology. 25(4). 897–911. 2 indexed citations
8.
Navarro-Martín, Arturo, Patricia Calvo, Rodolfo Chicas-Sett, et al.. (2022). Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?. World Journal of Clinical Oncology. 13(2). 101–115. 5 indexed citations
9.
Rodríguez, Núria, Arturo Navarro-Martín, Rodolfo Chicas-Sett, et al.. (2022). GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. World Journal of Clinical Oncology. 13(4). 237–266. 12 indexed citations
10.
Montés, Ana Fernández, Guillermo de Velasco, Rodolfo Chicas-Sett, et al.. (2021). Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice. Current Treatment Options in Oncology. 22(3). 26–26. 6 indexed citations
11.
Cobo, Manuel, et al.. (2021). One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study. BMJ Supportive & Palliative Care. 13(e2). e318–e326. 5 indexed citations
12.
13.
Chicas-Sett, Rodolfo, et al.. (2019). OC-0060 I-SABR induces local and abscopal responses in metastatic patients after failure to ICI treatment. Radiotherapy and Oncology. 133. S24–S24. 2 indexed citations
14.
Chicas-Sett, Rodolfo, et al.. (2018). Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies. Reports of Practical Oncology & Radiotherapy. 24(1). 86–91. 16 indexed citations
15.
16.
Chicas-Sett, Rodolfo, et al.. (2017). Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review. Clinical and Translational Radiation Oncology. 9. 5–11. 73 indexed citations
17.
Chicas-Sett, Rodolfo, et al.. (2016). Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage. Cureus. 8(4). e572–e572. 1 indexed citations
18.
Chicas-Sett, Rodolfo, et al.. (2016). An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience. Journal of Contemporary Brachytherapy. 4(4). 349–355. 2 indexed citations
19.
Roldán, S., et al.. (2016). PO-0959: Dosimetric outcome and perioperative toxicity using Utrecht applicator in cervical brachytherapy. Radiotherapy and Oncology. 119. S466–S467. 2 indexed citations
20.
Chicas-Sett, Rodolfo, et al.. (2015). A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?. International Cancer Conference Journal. 5(2). 77–81. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Ziegler Breakdown of academic impact, for papers by Gregory Vlacich Breakdown of academic impact, for papers by Felix Ho Breakdown of academic impact, for papers by Zeming Mo Breakdown of academic impact, for papers by Eren Celik Breakdown of academic impact, for papers by D. Spielsinger Breakdown of academic impact, for papers by Kilian Salerno May Breakdown of academic impact, for papers by Manabu Arai Breakdown of academic impact, for papers by Fernando M. Gómez
Rankless by CCL
2026